Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
Abnormal elevation of amyloid β-peptide (Aβ) levels in the brain is the primary trigger for neuronal cell death specific to Alzheimer’s disease (AD). It is now evident that Aβ levels in the brain are manipulable due to a dynamic equilibrium between its production from the amyloid precursor protein (...
Main Authors: | Natalia N Nalivaeva, Nikolai D Belyaev, Caroline eKerridge, Anthony J Turner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00235/full |
Similar Items
-
Hypoxia affects neprilysin expression through caspase activation and an APP intracellular domain-dependent mechanism
by: Caroline eKerridge, et al.
Published: (2015-11-01) -
Lipid rafts and Alzheimer’s disease: protein-lipid interactions and perturbation of signalling
by: David A. Hicks, et al.
Published: (2012-06-01) -
APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
by: Marcus Otto Grimm, et al.
Published: (2015-05-01) -
Neprilysin and Aβ-clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer´s disease
by: Marcus O Grimm, et al.
Published: (2013-12-01) -
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
by: Natalia N. Nalivaeva, et al.
Published: (2018-11-01)